Skip to main content

This job has expired

You will need to login before you can apply for a job.

Stability Associate, Quality Control

Employer
Molecular Templates, Inc.
Location
Austin, TX, USA
Start date
Jan 22, 2021

View more

Discipline
Quality, Quality Control
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Lone Star Bio

Job Details

Company Description:

Molecular Templates is a clinical stage biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. We believe our proprietary biologic drug platform technology, referred to as engineered toxin bodies, or ETBs, provides a differentiated mechanism of action that may address some of the limitations associated with currently available cancer therapeutics. ETBs utilize a genetically engineered form of Shiga-like Toxin A subunit, or SLTA, a ribosome inactivating bacterial protein, that can be targeted to specifically destroy cancer cells. Additional information about Molecular Templates can be obtained at www.mtem.com.

Position Overview:

Molecular Templates is seeking an experienced QC Stability Associate to join our Quality Department. The Stability Associate will primarily support initiation and execution of stability protocols, management of the onsite Stability Inventory, process incoming and outgoing stability samples, data entry, review of data trends, and assist the Stability Coordinator in other activities related to the stability program. The successful stability associate will have excellent organizational and time-management skills, verbal, and written communication skills, plus an ability to apply attention to detail.

Job Responsibilities will include:
  • Manage onsite Stability Inventory
  • Process outgoing samples to CROs
  • Input stability data and review data for trends to support reports to management, such as annual product review
  • Complete input of all backlogged data into Stability database
  • Build studies in database
  • Generate process related metrics, monitoring for efficiency
  • Assist in generation and closure of stability-related deviations, change controls and CAPAs
  • Provide support for regulatory filings, audits, and inspections
  • Support Data Review group to inventory and manage completed data packets, as needed
  • Assist in QC stability testing, as needed

Qualifications:
  • Bachelor's degree from accredited institution in a scientific discipline, preferred
  • A minimum 2 years' experience in GMP laboratory environment (analytical/chemistry), required
  • Experience in biopharmaceutical industry, preferred
  • Demonstrated knowledge of cGMP regulations, quality systems and regulatory requirements
  • Excellent project management, time management, and multi-tasking skills
  • Excellent written and verbal communication skills
  • Excellent computer skills with knowledge of Microsoft Suite including Excel, Word and statistical analysis software
  • Ability to manage competing priorities or projects
  • Ability to work under supervision and/or function independently, exercise good judgement and work in a team-based environment
  • Ability to identify problems and solutions then act to resolve
  • Demonstrated ability to resolve operational and strategic issues
  • Ability to apply attention to detail as applied to data review and compliance
  • High degree of reliability and professionalism

Reporting Structure:

This position has no supervisory responsibilities. This position reports to the QC Stability Coordinator.

Molecular Templates, Inc. is an Equal Opportunity Employer and offers competitive salaries and benefits.

Molecular Templates Inc https://mtem.isolvedhire.com

Company

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development.  Additional information about MTEM can be obtained at www.mtem.com.  

OWNERSHIP: Public

STOCK SYMBOL: MTEM

STOCK EXCHANGE: NASDAQ

Company info
Website
Phone
512-869-1555
Location
9301 Amberglen Blvd, Ste 100
Austin
TX
78729
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert